ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 202 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $226,489 | +1158.3% | 10,868 | +2902.2% | 0.02% | +1400.0% |
| Q2 2020 | $18,000 | -52.6% | 362 | -59.0% | 0.00% | 0.0% |
| Q4 2019 | $38,000 | +5.6% | 884 | -34.8% | 0.00% | -50.0% |
| Q2 2019 | $36,000 | -30.8% | 1,355 | -30.1% | 0.00% | -33.3% |
| Q1 2019 | $52,000 | -93.3% | 1,939 | -96.2% | 0.00% | -93.9% |
| Q2 2018 | $774,000 | -13.2% | 50,700 | +58.4% | 0.05% | -41.7% |
| Q2 2017 | $892,000 | +82.0% | 32,000 | +107.8% | 0.08% | +64.7% |
| Q3 2016 | $490,000 | -17.2% | 15,400 | -35.1% | 0.05% | -48.0% |
| Q4 2013 | $592,000 | -6.3% | 23,720 | +3.0% | 0.10% | -3.9% |
| Q3 2013 | $632,000 | -40.0% | 23,020 | -60.3% | 0.10% | -54.9% |
| Q2 2013 | $1,053,000 | – | 58,000 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |